Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Aug 10, 2014; 5(3): 520-528
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.520
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.520
Table 1 Studies of green tea catechins on mammary tumorigenesis in animal models or clinical trials
Ref. | Model | Intervention | Main results |
Kavanagh et al[30], 2001 | 4-wk-old female Sprague-Dawley rats | Treated with green tea catechins after exposure to DMBA | Green tea extract given after initiation significantly increases mammary tumor latency and decreases tumor weight and metastases in DMBA-treated rats |
Hirose et al[34], 2002 | 6-wk-old female F344 rats | PhIP alone or PhIP plus 1% green tea catechins for 52 wk | 1% green tea catechins were associated only with reduced mean size of mammary tumors without affecting the total number of mammary tumors |
Whitsett et al[35] ,2006 | Female Sprague–Dawley CD rats | Treated with DMBA to induce breast cancer after previous exposure to green tea catechins or control diet throughout life | Animals exposed throughout life to EGCG in the drinking water showed a decrease in the latency to first tumor development, although there was no significant difference as compared with the control group with respect to second and third tumor latency. Furthermore, the number of tumors per rat in EGCG-exposed rats was not significantly different from the controls |
Kaur et al[36], 2007 | C3(1)SV40T, t antigen transgenic multiple mammary adenocarcinoma mice | Mice received green tea catechins in drinking water at 0.01% (w/v) for 25 wk, with water as control | Green tea catechins delayed carcinogenesis as evidenced by a significant decrease in the volume and size of tumors in the mice exposed to green tea extract |
Lubet et al[37], 2007 | 50-d-old female Sprague-Dawley rats | Intravenous injection of methyl-nitrosourea (75 mg/kg bw) via the jugular vein. 5 d after treatment with the carcinogen, Poly E was given by gavage at 1000 and 333 mg/kg bw/d. | There was no effect of Poly E on the latency period of the mammary tumors. The high and low doses of Poly E decreased the number of mammary tumors by 14% and reduced the weight of the tumors by 30% and 21%, respectively |
Sakata et al[31], 2011 | C3H/OuJ mice carrying preneoplastic lesions | Treated with EGCG and tamoxifen alone or in combination | The tumor incidences were decreased in the green tea extract, tamoxifen, and green tea extract and tamoxifen groups. Importantly, in the group treated with green tea extract and tamoxifen, no tumors developed |
Crew et al[32],2012 | Women with a history of histologically confirmed resected stage I-III, estrogen and progesterone receptor negative breast carcinoma. | Participants received either Poly E delivering 400, 600, or 800 mg of EGCG (2-4 capsules) twice daily with food or matching placebo for 6 mo | (1) The MTD for Poly E should be 600 mg twice daily; (2) There was about a 70% reduction in serum estradiol levels (P = 0.05) and a significant decrease in SHBG (P = 0.03) at 6 mo compared with baseline in the Poly E group. However, these changes did not differ significantly compared with the placebo group due to smaller numbers; and (3) No changes in breast tissue proliferation were observed. |
- Citation: Li MJ, Yin YC, Wang J, Jiang YF. Green tea compounds in breast cancer prevention and treatment. World J Clin Oncol 2014; 5(3): 520-528
- URL: https://www.wjgnet.com/2218-4333/full/v5/i3/520.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i3.520